The rate of bone loss is associated with an increased risk of fracture in postmenopausal women. The OFELY study.

被引:0
|
作者
Sornay-Rendu, E [1 ]
Munoz, F [1 ]
Duboeuf, R [1 ]
Delmas, PD [1 ]
机构
[1] INSERM, Unit 403, Lyon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S91 / S91
页数:1
相关论文
共 50 条
  • [21] Bone Microarchitecture Assessed by HR-pQCT as Predictor of Fracture Risk in Postmenopausal Women: The OFELY Study
    Sornay-Rendu, Elisabeth
    Boutroy, Stephanie
    Duboeuf, Francois
    Chapurlat, Roland D.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) : 1243 - 1251
  • [22] HAND OSTEOARTHRITIS IS ASSOCIATED WITH A BETTER BONE MICROARCHITECTURE IN POSTMENOPAUSAL WOMEN: THE OFELY STUDY
    Sornay-Rendu, E.
    Duboeuf, F.
    Chapurlat, R.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S222 - S223
  • [23] Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study
    Garnero, P
    Borel, O
    SornayRendu, E
    Arlot, ME
    Delmas, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (06) : 827 - 834
  • [24] Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY Study
    Rousseau, J. C.
    Sornay-Rendu, E.
    Bertholon, C.
    Chapurlat, R.
    Garnero, P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (07): : 2533 - 2539
  • [25] Soy isoflavones: Increased bone turnover and less bone loss at the hip in postmenopausal women.
    Fitzpatrick, LA
    Vincent, A
    Oberg, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S161 - S161
  • [26] SERUM PERIOSTIN IS INDEPENDENTLY ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN: A 7 YEARS PROSPECTIVE ANALYSIS OF THE OFELY STUDY
    Rousseau, Jean-Charles
    Sornay-Rendu, Elisabeth
    Bertholon, Cindy
    Chapurlat, Roland
    Garnero, Patrick
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S47 - S48
  • [27] Alveolar bone loss and bone density in postmenopausal women.
    Hildebolt, CF
    Dotson, M
    Yokoyama, N
    Muckerman, J
    Pilgram, TE
    Hauser, J
    Cohen, S
    Kardaris, E
    Vannier, M
    Civitelli, R
    [J]. JOURNAL OF DENTAL RESEARCH, 1997, 76 : 759 - 759
  • [28] ASSOCIATION OF SERUM SCLEROSTIN WITH BONE TURNOVER, ENDOGENOUS HORMONES, BONE MINERAL DENSITY (BMD) AND FRACTURE RISK IN POSTMENOPAUSAL WOMEN: THE OFELY STUDY
    Garnero, Patrick
    Sornay-Rendu, Elisabeth
    Munoz, Francoise
    Borel, Olivier
    Chapurlat, Roland
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 341 - 341
  • [29] ASSOCIATION OF SERUM SCLEROSTIN WITH BONE TURNOVER, ENDOGENOUS HORMONES, BONE MINERAL DENSITY (BMD) AND FRACTURE RISK IN POSTMENOPAUSAL WOMEN: THE OFELY STUDY
    Garnero, Patrick
    Sornay-Rendu, Elisabeth
    Munoz, Francoise
    Borel, Olivier
    Chapurlat, Roland
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 15 - 16
  • [30] A functional interleukine-6 gene polymorphism predicts peak bone mineral density, but not postmenopausal bone loss and bone turnover in women: The OFELY study.
    Garnero, P
    Borel, O
    Sornay-Rendu, E
    Woo, P
    Delmas, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S473 - S473